miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
Lingyin Ge(Cedars-Sinai Medical Center), Peter Chen(Cedars-Sinai Medical Center)
Cited by 49
Related Papers
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
|The Lancet Respiratory Medicine|2022|127
MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation
|PLoS ONE|2009|118
Integrative genomic identification of therapeutic targets for pancreatic cancer
|Cell Reports|2025|7